Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Evaluation of Cetuximab and RAD001 in Patients With Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01637194
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:17.666142+00:00
Published At
2012-07-11T00:00:00+00:00
Record Updated At
2012-07-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Adenoid Cystic Carcinoma of the Oral Cavity", "Recurrent Basal Cell Carcinoma of the Lip", "Recurrent Colon Cancer", "Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity", "Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity", "Recurrent Lymphoepithelioma of the Nasopharynx", "Recurrent Lymphoepithelioma of the Oropharynx", "Recurrent Metastatic Squamous Neck Cancer With Occult Primary", "Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity", "Recurrent Mucoepidermoid Carcinoma of the Oral Cavity", "Recurrent Salivary Gland Cancer", "Recurrent Squamous Cell Carcinoma of the Hypopharynx", "Recurrent Squamous Cell Carcinoma of the Larynx", "Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity", "Recurrent Squamous Cell Carcinoma of the Nasopharynx", "Recurrent Squamous Cell Carcinoma of the Oropharynx", "Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity", "Recurrent Verrucous Carcinoma of the Larynx", "Recurrent Verrucous Carcinoma of the Oral Cavity", "Stage IV Adenoid Cystic Carcinoma of the Oral Cavity", "Stage IV Basal Cell Carcinoma of the Lip", "Stage IV Lymphoepithelioma of the Nasopharynx", "Stage IV Lymphoepithelioma of the Oropharynx", "Stage IV Mucoepidermoid Carcinoma of the Oral Cavity", "Stage IV Squamous Cell Carcinoma of the Hypopharynx", "Stage IV Squamous Cell Carcinoma of the Larynx", "Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity", "Stage IV Squamous Cell Carcinoma of the Nasopharynx", "Stage IV Squamous Cell Carcinoma of the Oropharynx", "Stage IV Verrucous Carcinoma of the Larynx", "Stage IV Verrucous Carcinoma of the Oral Cavity", "Stage IVA Colon Cancer", "Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity", "Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity", "Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity", "Stage IVA Salivary Gland Cancer", "Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity", "Stage IVB Colon Cancer", "Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity", "Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity", "Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity", "Stage IVB Salivary Gland Cancer", "Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity", "Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity", "Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity", "Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity", "Stage IVC Salivary Gland Cancer", "Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity", "Tongue Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2012-07-11"
protocolSection.identificationModule.nctId
"NCT01637194"
protocolSection.identificationModule.officialTitle
"A Phase I Evaluation of Cetuximab and RAD001 in Patients With Solid Tumors"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
  • Recurrent Basal Cell Carcinoma of the Lip (protocolSection.conditionsModule.conditions)
  • Recurrent Colon Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Recurrent Lymphoepithelioma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Recurrent Lymphoepithelioma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Recurrent Metastatic Squamous Neck Cancer With Occult Primary (protocolSection.conditionsModule.conditions)
  • Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Recurrent Mucoepidermoid Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
  • Recurrent Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Recurrent Verrucous Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Recurrent Verrucous Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IV Adenoid Cystic Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IV Basal Cell Carcinoma of the Lip (protocolSection.conditionsModule.conditions)
  • Stage IV Lymphoepithelioma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Lymphoepithelioma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Mucoepidermoid Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Verrucous Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Stage IV Verrucous Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVA Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVA Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVB Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVB Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Stage IVC Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Tongue Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.